Similar Articles
601 Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
602 Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
603 Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection
604 Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma
605 Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma
606 Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
607 Utility of positron emission tomography-computed tomography scan in detecting residual hepatocellular carcinoma post treatment: Series of case reports
608 Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
609 Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
610 Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA